You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Esophageal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer Trial in Ramat Gan (CPAP)

Recruiting
  • Esophageal Cancer
  • CPAP
  • Ramat Gan, Israel
    Sheba Medical Center
Sep 13, 2023

Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)

Not yet recruiting
  • Esophageal Cancer
  • Esophageal Neoplasms
  • Prehabilitation Program
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Patients in Esophageal Cancer Clinical Research

Not yet recruiting
  • Esophageal Cancer
    • (no location specified)
    Apr 14, 2023

    Prevent Anastomotic Leakage After Esophagectomy Due to

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • Eso-SPONGE®
    • Barcelona, Catalunya, Spain
      Hospital Clinic de Barcelona
    Oct 20, 2023

    Microbiome of Esophageal Cancer Patients and Post Esophagectomy

    Recruiting
    • Esophageal Tumors
      • Haifa, Israel
        Rambam Health Care Campus
      Nov 13, 2023

      Follow-up Strategy for Esophageal Cancer Patients

      Active, not recruiting
      • Esophagus Cancer
      • follow-up with different time intervals
      • Guangzhou, Guangdong, China
        Jianhua Fu
      Sep 13, 2023

      Patient Participation in Lung and Esophageal Cancer Patients

      Recruiting
      • Lung Cancer
      • Esophageal Cancer
        • Guangzhou, China
          Sun Yat-sen University
        Aug 25, 2023

        Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

        Recruiting
        • Esophageal Neoplasm Metastatic
        • Esophageal Cancer Stage IVb
        • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
        • +3 more
        • Beijing, Beijing, China
          Cancer hospital, CAMS
        Oct 19, 2023

        Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

        Enrolling by invitation
        • Esophageal Carcinoma
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital of Nanjing Medical University
        Sep 19, 2023

        Retrospective Review of Esophageal Cancer at MSKCC

        Recruiting
        • Esophageal Cancer
        • Esophagus Cancer
        • Esophagectomy
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Jan 23, 2023

        Esophageal Cancer Trial in Taoyuan (PET/MRI)

        Completed
        • Esophageal Cancer
        • PET/MRI
        • Taoyuan, Taiwan
          Linkou Chang Gung Memorial Hospital
        May 9, 2023

        Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

        Recruiting
        • Esophageal Carcinoma
        • Shijiazhuang, Hebei, China
          Fourth Hospital of Hebei Medical University
        Aug 20, 2023

        Esophageal Cancer Trial in Sohag (Minimally Invasive Surgery for Esophageal Cancer)

        Not yet recruiting
        • Esophageal Cancer
        • Minimally Invasive Surgery for Esophageal Cancer
        • Sohag, Egypt
          Sohag university
        Dec 14, 2022

        Dose to Cardiac Substructures on Survival in Esophageal Cancer

        Recruiting
        • Esophagus Cancer
          • Brest, France
            Chu Brest
          Aug 16, 2023

          Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

          Not yet recruiting
          • Immunotherapy;Envafolimab; Esophageal Cancer
          • (no location specified)
          Apr 24, 2023

          Esophageal Cancer Trial (Blood sample)

          Not yet recruiting
          • Esophageal Cancer
          • Blood sample
          • (no location specified)
          Jan 19, 2023

          Esophageal Cancer Trial in Taoyuan (PET/MRI)

          Completed
          • Esophageal Cancer
          • PET/MRI
          • Taoyuan, Taiwan
            Linkou Chang Gung Memorial Hospital
          May 9, 2023

          Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

          Not yet recruiting
          • Esophageal Cancer
          • +2 more
          • Beijing, Beijing, China
            Beijing Cancer Hospital
          Aug 22, 2023

          A Multicenter, Cross-sectional Study on Quality of Life in

          Not yet recruiting
          • Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival
          • questionnaire investigation
          • Tianjin, Tianjin, China
            Tianjin Medical University Cancer Institute & Hospital
          Apr 24, 2023

          Symptoms Based on Patient-reported Outcomes in Immunotherapy for

          Not yet recruiting
          • Esophageal Cancer
          • +2 more
            • Guangzhou, Guangdong, China
              Guangdong Provincial People's Hospital
            Aug 24, 2023

            Esophageal Cancer Risk Registry

            Recruiting
            • Esophageal Cancer
            • +4 more
            • Survey of client health, personal habits, family history
            • +3 more
            • Pittsburgh, Pennsylvania
              Department of Cardiothoracic Surgery
            Jan 23, 2023

            Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)

            Recruiting
            • Esophageal Cancer
            • +3 more
            • Taizhou, Zhejiang, China
            • +1 more
            Apr 15, 2023

            Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)

            Recruiting
            • Esophageal Cancer
            • Utidelone and anlotinib
            • Weihui, Henan, China
            • +2 more
            May 10, 2023

            Atelectasis, Postoperative Trial in Shenyang (30%Oxygen, 60%Oxygen)

            Recruiting
            • Atelectasis, Postoperative
            • Shenyang, Liaoning, China
              the First Hospital of China Medical University
            Aug 22, 2023

            Esophageal Squamous Cell Carcinoma Trial in Chongqing (Tislelizumab)

            Not yet recruiting
            • Esophageal Squamous Cell Carcinoma
            • Chongqing, Chongqing, China
              Army Medical Center of the People's Liberation Army
            May 26, 2023